Novartis-GSK asset swap offers template for pharma and beyond
April 23, 2014 at 13:53 PM EDT
LONDON, April 23 (Reuters) - The loud welcome given by investors to this week's deal for Novartis and GlaxoSmithKline to trade more than $20 billion of assets could trigger more pacts in the pharmaceuticals sector and beyond.